Adjusted EBITDA loss widened to $36.5 million from $23.7 million in the prior-year period due to increased investments.
Cash, cash equivalents, and investments totaled $656.8 million as of June 30, 2025, with a subsequent $1 billion equity raise at a 25% premium boosting pro forma cash to $1.6 billion.
IonQ reported Q2 2025 revenue of $20.7 million, beating the high end of guidance by 15%.
Net loss for Q2 2025 was $177.5 million compared to $37.6 million in the prior-year period, including a $39.6 million noncash warrant liability loss.
R&D expenses increased 231% to $103.4 million reflecting heavy investment in technology and headcount growth.
Stock-based compensation expense surged to $99.2 million from $21 million year-over-year due to incentives for new hires and acquisitions.
Total operating costs rose 201% year-over-year to $181.3 million, driven by R&D, sales and marketing, and G&A expenses.